271 related articles for article (PubMed ID: 7798537)
1. Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma.
Fischer AR; Rosenberg MA; Lilly CM; Callery JC; Rubin P; Cohn J; White MV; Igarashi Y; Kaliner MA; Drazen JM
J Allergy Clin Immunol; 1994 Dec; 94(6 Pt 1):1046-56. PubMed ID: 7798537
[TBL] [Abstract][Full Text] [Related]
2. Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma.
Sladek K; Szczeklik A
Eur Respir J; 1993 Mar; 6(3):391-9. PubMed ID: 8386106
[TBL] [Abstract][Full Text] [Related]
3. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin.
Israel E; Fischer AR; Rosenberg MA; Lilly CM; Callery JC; Shapiro J; Cohn J; Rubin P; Drazen JM
Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1447-51. PubMed ID: 8256883
[TBL] [Abstract][Full Text] [Related]
4. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.
Dahlén B; Nizankowska E; Szczeklik A; Zetterström O; Bochenek G; Kumlin M; Mastalerz L; Pinis G; Swanson LJ; Boodhoo TI; Wright S; Dubé LM; Dahlén SE
Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1187-94. PubMed ID: 9563738
[TBL] [Abstract][Full Text] [Related]
5. Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics.
Szczeklik A; Sladek K; Dworski R; Nizankowska E; Soja J; Sheller J; Oates J
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1608-14. PubMed ID: 8970343
[TBL] [Abstract][Full Text] [Related]
6. Effect of continuous allergen challenge on clinical symptoms and mediator release in dust-mite-allergic patients.
Horak F; Toth J; Hirschwehr R; Marks B; Stübner UP; Jäger S; Berger U; Schleinzer K; Günczler P
Allergy; 1998 Jan; 53(1):68-72. PubMed ID: 9491231
[TBL] [Abstract][Full Text] [Related]
7. Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis.
Di Lorenzo G; Drago A; Esposito Pellitteri M; Candore G; Colombo A; Gervasi F; Pacor ML; Purello D'Ambrosio F; Caruso C
Int Arch Allergy Immunol; 2001 Jun; 125(2):164-75. PubMed ID: 11435734
[TBL] [Abstract][Full Text] [Related]
8. Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis.
Knani J; Campbell A; Enander I; Peterson CG; Michel FB; Bousquet J
J Allergy Clin Immunol; 1992 Dec; 90(6 Pt 1):880-9. PubMed ID: 1334102
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory cell populations and cytokine mRNA expression in the nasal mucosa in aspirin-sensitive rhinitis.
Varga EM; Jacobson MR; Masuyama K; Rak S; Till SJ; Darby Y; Hamid Q; Lund V; Scadding GK; Durham SR
Eur Respir J; 1999 Sep; 14(3):610-5. PubMed ID: 10543283
[TBL] [Abstract][Full Text] [Related]
10. Nasal and bronchial responses to flour-inhalation in subjects with occupationally induced allergy affecting the airway.
Górski P; Krakowiak A; Ruta U
Int Arch Occup Environ Health; 2000 Sep; 73(7):488-97. PubMed ID: 11057418
[TBL] [Abstract][Full Text] [Related]
11. Histamine and tryptase in nasal lavage fluid after allergen challenge: effect of 1 week of pretreatment with intranasal azelastine or systemic cetirizine.
Jacobi HH; Skov PS; Poulsen LK; Malling HJ; Mygind N
J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):768-72. PubMed ID: 10329808
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical characterization of cellular infiltrate in nasal polyp from aspirin-sensitive asthmatic patients.
Park HS; Nahm DH; Park K; Suh KS; Yim HE
Ann Allergy Asthma Immunol; 1998 Sep; 81(3):219-24. PubMed ID: 9759797
[TBL] [Abstract][Full Text] [Related]
13. Relationship between nasal hyperreactivity, mediators and eosinophils in patients with perennial allergic rhinitis and controls.
de Graaf-in t Veld C; Garrelds IM; Koenders S; Gerth van Wijk R
Clin Exp Allergy; 1996 Aug; 26(8):903-8. PubMed ID: 8877155
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory mediators in naturally occurring rhinitis.
Wilson SJ; Lau L; Howarth PH
Clin Exp Allergy; 1998 Feb; 28(2):220-7. PubMed ID: 9515596
[TBL] [Abstract][Full Text] [Related]
15. Concentrations of chemical mediators in nasal secretions after nasal allergen challenges in atopic patients.
Wang D; Clement P; Smitz J; Derde MP
Eur Arch Otorhinolaryngol; 1995; 252 Suppl 1():S40-3. PubMed ID: 7734974
[TBL] [Abstract][Full Text] [Related]
16. Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs.
Zembowicz A; Mastalerz L; Setkowicz M; Radziszewski W; Szczeklik A
Arch Dermatol; 2003 Dec; 139(12):1577-82. PubMed ID: 14676074
[TBL] [Abstract][Full Text] [Related]
17. Effect of six-hour exposure to nitrogen dioxide on early-phase nasal response to allergen challenge in patients with a history of seasonal allergic rhinitis.
Wang JH; Devalia JL; Duddle JM; Hamilton SA; Davies RJ
J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):669-76. PubMed ID: 7499684
[TBL] [Abstract][Full Text] [Related]
18. The effect of short-term immunotherapy with molecular standardized grass and rye allergens on eosinophil cationic protein and tryptase in nasal secretions.
Klimek L; Wolf H; Mewes T; Dormann D; Reske-Kunz A; Schnitker J; Mann W
J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):47-53. PubMed ID: 9893184
[TBL] [Abstract][Full Text] [Related]
19. Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group.
Liu MC; Dubé LM; Lancaster J
J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):859-71. PubMed ID: 8939149
[TBL] [Abstract][Full Text] [Related]
20. Airway function correlates with circulating eosinophil, but not mast cell, markers of inflammation in childhood asthma.
Rao R; Frederick JM; Enander I; Gregson RK; Warner JA; Warner JO
Clin Exp Allergy; 1996 Jul; 26(7):789-93. PubMed ID: 8842552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
